aser enucleation of the prostate for benign prostatic hyperplasia

Not Applicable

• Conditions: N40; Hyperplasia of prostate

• Registration Number: DRKS00008206
• Lead Sponsor: Asklepios Klinik Barmbek

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-05-07
• Study Completion: 2018-03-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 110

Inclusion Criteria

•IPSS-Score = 12
•Uroflowmetrie Qmax = 15ml/s
•male patient =18 years
and/or ineffective medical therapy of BPO, history of recurrent urinary tract infections, bladder stones, history of recurrent urinary retention, postrenal failure due to BPO

Exclusion Criteria

•prevoius surgery of urinary tract/prostate
•known urrethral stricture
•known prostate cancer
•neurogenic disorder of bladder function
•not willing to take part in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
objective reduction of miciton parameters (international prostate symptom score (IPSS), Qmax) after 1, 6, 12, 24 months

Secondary Outcome Measures

Name	Time	Method
collection of intra and postoperative complications